Notice NOT-MH-23-385 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-350 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-182 from the NIH Guide for Grants and Contracts

Notice NOT-AI-23-067 from the NIH Guide for Grants and Contracts

Notice NOT-HL-23-111 from the NIH Guide for Grants and Contracts

Notice NOT-HS-23-022 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-180 from the NIH Guide for Grants and Contracts

Notice NOT-EB-23-017 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-375 from the NIH Guide for Grants and Contracts

Notice NOT-TR-23-026 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-088 from the NIH Guide for Grants and Contracts

Notice NOT-AT-24-013 from the NIH Guide for Grants and Contracts

Notice NOT-AG-23-046 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-RM-23-016 from the NIH Guide for Grants and Contracts. This NOFO will support a Consortium Organization and Data Collaboration Center (CODCC) that will serve as an organizational and cooperation hub specifically for the Human Virome Program (HVP) consortium.

Notice NOT-CA-23-090 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-275 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to encourage applications for research projects within the mission of either the NIAID mission or the NIDDK. This NOFO seeks to support either (a) a New Investigator (NI), an individual who has not previously competed successfully for substantial, independent funding from NIH, or (b) are an 'At-Risk' investigator, an individual who had prior support as a PD/PI on a substantial independent research award and unless successful in securing a substantial research grant award in the current fiscal year, will have no substantial research grant funding in the following fiscal year, from diverse backgrounds, including those from groups underrepresented in the health-related sciences. The purpose of this funding opportunity announcement is to encourage applications for research projects within the mission of either the NIAID or the NIDDK.

Notice NOT-NR-23-017 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-23-056 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for the Computational Models of Influenza Immunity Cooperative Agreement Program. The program will employ computational modeling and immunologic studies to advance our understanding of the requirements for improving anti-influenza immunity, including inducing broad immune protection and enhancing immune durability. This program will help inform design of universal or improved seasonal flu vaccines. Projects may lead to a better understanding of how pre-existing immunity and repeat exposures (natural infection and/or vaccines) shape an individuals immune landscape. Predictive modeling of adjuvants/vaccine formulations and experimental validation supported by this program should lead to enhanced host immune responses and universal or improved seasonal influenza vaccine efficacy.

Notice NOT-HL-23-106 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-RM-23-019 from the NIH Guide for Grants and Contracts. The RFA will solicit applications for the Human Virome Program under the NIH Common Fund to establish multicomponent Virome Centers that will focus on the identification and characterization of the human virome in longitudinal and diverse cohorts across several body sites and tissues. The multicore structure of each center will allow for specialized and broad expertise in isolating viruses (circulating, proviral, integrated forms) and a coordinated, and comprehensive research program for recruiting diverse participants, collecting and analyzing many types of biospecimens, standardizing and analyzing center data, and addressing ethical, social and legal implications of human virome research. The Centers will also work collaboratively across the program consortium of separately awarded investigative teams in the coordination and management of consortium policies and practices. Similar to other U54 initiatives, the virome centers have unique objectives and specific review criteria and core specifications outlined in the RFA, and currently, there are no existing study sections with the necessary expertise to review this complex program.